menu search

Nexcella, inc., a subsidiary of immix biopharma, announces poster presentation at the european society for blood and marrow transplantation and european hematology association 5th annual european car

Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands Februa...

December 28, 2022, 1:00 pm

Nexcella, inc., a subsidiary of immix biopharma, announces poster presentation at the european society for blood and marrow transplantation and european hematology association 5th annual european car

Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands Februa...

December 28, 2022, 1:00 pm

Sana biotechnology highlights hypoimmune allogeneic car t cell programs and in vivo technology platform with six presentations at 2022 ash annual meeting

transplanted hypoimmune (HIP)-modified allogeneic CD19-targeted CAR T cells control CD19+ tumor cells i...

December 11, 2022, 10:30 pm

In8bio to present positive early data from ongoing phase 1 study of inb-100 at the 64th american society of hematology annual meeting

NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company discovering and developing innovat...

November 3, 2022, 9:10 am

Talaris therapeutics: plenty of upside remains, but so does the risk

Shares of cell therapy concern Talaris Therapeutics crashed nearly 70% after GvHD outcomes in three Phase 3 trial kidney ...

August 29, 2022, 7:59 am

Why aditxt shares are rallying today?

Aditxt Inc's (NASDAQ: ADTX) therapeutic program Adimune has completed a toxicology study indicating a favorable safety profile of ADI-100 for rejec...

July 8, 2022, 9:51 am

Cymabay: long-term potential based on prior pbc trial results

Results from the phase 3 RESPONSE study, which is using Seladelpar for the treatment of patients with primary biliary Cholangitis, are expected in 202...

June 27, 2022, 6:52 pm

Miromatrix announces participation in h.c. wainwright global investment conference

EDEN PRAIRIE, Minn., May 17, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology fo...

May 17, 2022, 4:39 pm

Vera therapeutics selected to present interim phase 2 data for mau868 to treat bk virus in kidney transplant patients as oral late-breaker at the american transplant congress 2022

BRISBANE, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late-stage biotechnology company focused on developing an...

May 2, 2022, 7:06 pm

These charts explain why i'm holding this healthcare company

transplants are in high demand; this company is making the process of getting one smoother....

April 29, 2022, 7:05 am

Gamida cell posts updated omidubicel data in blood cancer patients

Gamida Cell Ltd (NASDAQ: GMDA) announced that updated infection data on omidubicel compared to umbilical cord blood ...

April 27, 2022, 12:41 pm

Vor bio to present at keystone symposia precision genome engineering meeting

Presentations showcase breadth of Vor Bio's multiplex editing capability including base editing of human hematopoietic stem and progenitor cells (HSPC...

April 25, 2022, 8:00 am

Actinium (atnm) up on commercialization deal with immedica

Actinium (ATNM) out-licenses exclusive rights to Iomab-B, an antibody radiation conjugate for facilitating bone-marrow ...

April 13, 2022, 6:04 pm

Jasper therapeutics to present updated data on jsp191 conditioning in scid patients at the 2022 clinical immunology society annual meeting

REDWOOD CITY, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on hematopoietic ce...

March 31, 2022, 8:00 am

Talaris therapeutics to participate at two upcoming investor conferences

BOSTON and LOUISVILLE, Ky., March 22, 2022 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company d...

March 22, 2022, 4:01 pm

Miromatrix to report fourth quarter and full year 2021 financial results

EDEN PRAIRIE, Minn., March 17, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology ...

March 17, 2022, 4:01 pm

Why are marker therapeutics shares trading lower on thursday?

Marker Therapeutics Inc (NASDAQ: MRKR) shares are trading lower after Roth Capital downgrades the company from Buy to Neutral and lowers the price t...

February 17, 2022, 1:08 pm

Why are marker therapeutics shares trading lower on thursday?

Marker Therapeutics Inc (NASDAQ: MRKR) shares are trading lower after Roth Capital downgrades the company from Buy to Neutral and lowers the price t...

February 17, 2022, 1:08 pm

Why are marker therapeutics shares trading lower on thursday?

Marker Therapeutics Inc (NASDAQ: MRKR) shares are trading lower after Roth Capital downgrades the company from Buy to Neutral and lowers the price t...

February 17, 2022, 1:08 pm

Revive therapeutics receives orphan drug designation for bucillamine in the prevention of ischemia-reperfusion injury during liver transplantation

Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for ...

February 16, 2022, 7:30 am


Search within

Pages Search Results: